Seagen, now part of Pfizer, is a global biotechnology company based in Bothell, WA, dedicated to revolutionizing cancer care through the development of transformative therapies that significantly impact patients' lives. With a focus on antibody-drug conjugates, Seagen has been a pioneer in novel cancer therapeutics for over 20 years, committed to addressing challenging clinical needs with safe and effective solutions.
Driven by a mission to make a real difference for those affected by cancer, Seagen's research efforts are dedicated to advancing innovative therapies for both solid tumors and blood-related cancers. The company's culture emphasizes integrity, collaboration, and diversity, uniting a global team of scientists, clinicians, advocates, and innovators in the shared goal of transforming cancer care.
Generated from the website